Literature DB >> 14702142

Molecular mechanism of neuropathic pain.

Hiroshi Ueda1, M Harunor Rashid.   

Abstract

Pain is the most common clinical symptom for which people seek medical care. Although effective therapy for inflammatory pain is possible, current therapy for neuropathic pain is still inadequate. Even the strongest painkiller, morphine, is reported to be ineffective against neuropathic pain in the clinic. The lack of effective therapeutic agents for neuropathic pain is due to the fact that its underlying mechanisms are still not fully understood. Recently, pain researchers have been trying to identify the cellular and molecular processes that lead to neuropathic pain. Understanding the molecular mechanisms of neuropathic pain would certainly provide a hope for the future development of effective therapies for this intractable painful disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14702142     DOI: 10.1358/dnp.2003.16.9.829343

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  3 in total

Review 1.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

2.  Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain.

Authors:  Makoto Inoue; Asuka Yamaguchi; Megumi Kawakami; Jerold Chun; Hiroshi Ueda
Journal:  Mol Pain       Date:  2006-08-16       Impact factor: 3.395

3.  Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice.

Authors:  Pao-Pao Yang; Geng-Chang Yeh; Eagle Yi-Kung Huang; Ping-Yee Law; Horace H Loh; Pao-Luh Tao
Journal:  J Biomed Sci       Date:  2015-09-22       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.